In this study, the impacts of hydroxyl (OH) group substitutions on the physico-chemical properties of levodopa (L-dopa), phenylalanine, and tyrosine were investigated using density functional theory and ab initio methods. L-dopa is an important therapeutic drug for Parkinson's disease and shares structural homology with the amino acids, whose structures differ only by OH substitutions in their phenyl side chains. The researchers found that while the backbone geometries of the aromatic molecules did not show any significant differences due to OH groups, their other molecular-level properties such as molecular dipole moment, electronic properties and aromaticity changed significantly. The core binding energy spectra indicated that atom sites undergoing modifications exhibited large energy shifts to accommodate changes in the intra-molecular chemical environment of the molecules. Specifically, binding energies of modified C 1s sites in the molecules shifted as much as 1.8 eV whereas electronic changes in their O 1s spectra occurred in higher energy regions (ca. 536 eV). Valence spectra provided enhanced insights into reactivity and chemical properties of aromatic molecules. The impacts of OH moieties on valence spectra were predominantly focused in an energy band <16 eV where frontier molecular orbitals displayed significant reorganization and energy shifts from amino acids to L-dopa. Of the three molecules studied, L-dopa had the least HOMO-LUMO energy gap which readily explained its proactivity as a drug compound. Furthermore, nuclear independent chemical shift calculations suggested that L-dopa also had more aromaticity features than those of amino acids. Overall, OH groups played a more prominent role in shaping physico-chemical properties of L-dopa which significantly improved its drug potency compared to phenylalanine and tyrosine. This study provides valuable insights into structure-property relationships between building blocks of proteins and drugs for future research endeavors aimed at developing novel therapeutic agents for various diseases.
SummaryScientists studied how adding hydroxyl (OH) groups to certain molecules affects their properties. They looked at three molecules: L-dopa, phenylalanine, and tyrosine. L-dopa is a medicine for Parkinson's disease that is similar in structure to amino acids. The scientists found that adding OH groups changed the electronic and chemical properties of the molecules. This study can help researchers make better medicines in the future.
Definitions
- Hydroxyl (OH) group: a group of atoms consisting of one oxygen atom and one hydrogen atom, often found in organic compounds
- Physico-chemical properties: characteristics of a substance related to its physical and chemical behavior
- Density functional theory: a method used in quantum mechanics to calculate the electronic structure of molecules
- Ab initio methods: calculations based on fundamental principles without using experimental data
- Aromaticity: a property of some organic compounds with alternating double bonds that makes them particularly stable
Exploring the Impact of Hydroxyl Group Substitutions on Physico-Chemical Properties of Levodopa
Levodopa (L-dopa) is an important therapeutic drug for Parkinson's disease, and it shares structural homology with two amino acids: phenylalanine and tyrosine. The only difference between them is that L-dopa has hydroxyl (OH) group substitutions in its phenyl side chains. In this study, researchers investigated how these OH groups affect the physico-chemical properties of L-dopa compared to those of the amino acids using density functional theory and ab initio methods.
Geometry Analysis
The researchers found that while the backbone geometries of all three molecules did not show any significant differences due to OH groups, their other molecular-level properties such as molecular dipole moment, electronic properties and aromaticity changed significantly. Specifically, core binding energy spectra indicated that atom sites undergoing modifications exhibited large energy shifts to accommodate changes in the intra-molecular chemical environment of the molecules. C 1s sites in particular shifted as much as 1.8 eV whereas O 1s spectra occurred in higher energy regions (ca. 536 eV).
Valence Spectra
Valence spectra provided enhanced insights into reactivity and chemical properties of aromatic molecules. The impacts of OH moieties on valence spectra were predominantly focused in an energy band lower than 16 eV where frontier molecular orbitals displayed significant reorganization and energy shifts from amino acids to L-dopa. Of all three molecules studied, L-dopa had the least HOMO-LUMO energy gap which readily explained its proactivity as a drug compound. Furthermore, nuclear independent chemical shift calculations suggested that L-dopa also had more aromaticity features than those of amino acids.
Conclusion
Overall, this study demonstrated that OH groups play a more prominent role in shaping physico-chemical properties of L-dopa which significantly improved its drug potency compared to phenylalanine and tyrosine by reducing its HOMO–LUMO gap and increasing its aromaticity features among others things.. This research provides valuable insights into structure–property relationships between building blocks of proteins and drugs for future research endeavors aimed at developing novel therapeutic agents for various diseases
Density functional theory and ab initio methods have been employed to address the impacts of hydroxyl (OH) group substitutions on the physico-chemical properties of levodopa (or L-dopa) against the natural amino acids, phenylalanine and tyrosine. L-dopa, which is an important therapeutic drug for Parkinson's disease, shares structural homology with the amino acids, whose structures differ only by OH substitutions in their phenyl side chains. It is revealed that the backbone geometries of the aromatic molecules do not show apparent OH-dependent differences; however, their other molecular-level properties, such as molecular dipole moment, electronic properties and aromaticity, change significantly. The core binding energy spectra indicate that the atom sites that undergo modifications exhibit large energy shifts, so as to accommodate the changes in the intra-molecular chemical environment of the molecules. The binding energies of the modified C 1s sites in the molecules shift as much as 1.8 eV, whereas the electronic changes in their O 1s spectra happen in the higher energy region (ca. 536 eV). The valence spectra provide enhanced insights on the reactivity and chemical properties of the aromatic molecules. The impacts of OH moieties on the valence spectra are predominantly focussed in the energy band<16 eV, where the frontier molecular orbitals display much reorganization and energy shifts from the amino acids to L-dopa. Of the three molecules, L-dopa also has the least HOMO-LUMO energy gap, which can readily explain its proactivity as a drug compound. Furthermore, the nuclear independent chemical shift calculations suggest that L-dopa also has more aromaticity features than those of the amino acids. The OH groups, therefore, play a more prominent role in shaping the physico-chemical properties of L-dopa, which significantly improve its drug potency.
